Bellevue Life Sciences Acquisition Corp. Warrant
Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquire companies in the healthcare industry. The company was founded in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp… Read more
Market Cap & Net Worth: Bellevue Life Sciences Acquisition Corp. Warrant (BLACW)
Bellevue Life Sciences Acquisition Corp. Warrant (NASDAQ:BLACW) has a market capitalization of $467.41 ($467.41) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #48970 globally and #15021 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bellevue Life Sciences Acquisition Corp. Warrant's stock price $0.05 by its total outstanding shares 9076 (9.08K).
Bellevue Life Sciences Acquisition Corp. Warrant Market Cap History: 2023 to 2025
Bellevue Life Sciences Acquisition Corp. Warrant's market capitalization history from 2023 to 2025. Data shows growth from $180.61 to $467.41 (0.00% CAGR).
Bellevue Life Sciences Acquisition Corp. Warrant Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bellevue Life Sciences Acquisition Corp. Warrant's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of BLACW by Market Capitalization
Companies near Bellevue Life Sciences Acquisition Corp. Warrant in the global market cap rankings as of March 18, 2026.
Key companies related to Bellevue Life Sciences Acquisition Corp. Warrant by market ranking:
- CLUS (PINK:CLUS): Ranked #1968 globally with a market cap of $8.00 Billion USD.
- Cartesian Growth Corporation II Warrant (NASDAQ:RENEW): Ranked #8546 globally with a market cap of $736.93 Million USD.
- Nh Special Purpose Acquisition 14 Co. Ltd (KQ:319400): Ranked #8994 globally with a market cap of $660.01 Million USD ( ₩966.39 Billion KRW).
- EQV Ventures Acquisition Corp. II (NYSE:EVAC): Ranked #10613 globally with a market cap of $465.51 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1968 | CLUS | PINK:CLUS | $8.00 Billion | $200.00 |
| #8546 | Cartesian Growth Corporation II Warrant | NASDAQ:RENEW | $736.93 Million | $138.87 |
| #8994 | Nh Special Purpose Acquisition 14 Co. Ltd | KQ:319400 | $660.01 Million | ₩30450.00 |
| #10613 | EQV Ventures Acquisition Corp. II | NYSE:EVAC | $465.51 Million | $10.07 |
Bellevue Life Sciences Acquisition Corp. Warrant Historical Marketcap From 2023 to 2025
Between 2023 and today, Bellevue Life Sciences Acquisition Corp. Warrant's market cap moved from $180.61 to $ 467.41, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $467.41 | +7.52% |
| 2024 | $434.74 | +140.70% |
| 2023 | $180.61 | -- |
End of Day Market Cap According to Different Sources
On Feb 13th, 2026 the market cap of Bellevue Life Sciences Acquisition Corp. Warrant was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $467.41 USD |
| MoneyControl | $467.41 USD |
| MarketWatch | $467.41 USD |
| marketcap.company | $467.41 USD |
| Reuters | $467.41 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.